Editorial
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 7, 2006; 12(33): 5272-5280
Published online Sep 7, 2006. doi: 10.3748/wjg.v12.i33.5272
Table 2 Indications for screening with anti-HCV antibody
Risk factors for which testing is indicated by all the guidelinesRisk factors for which testing is indicated by some of the guidelinesAdditional risk factors for which testing is not formally recommended
Intravenous drug use (past and present)Populations with high HCV prevalence[12,30]Injections with reusable glass syringes[32]
Blood transfusion or transplantation before 1992 (or by known HCV positive donor)Incarceration[12,33]Heavy marijuana use[34]
Administration of clotting factors before 1997Hepatitis B virus infection[12,33]Promiscuous sex[34]
Clinical or biochemical evidence for chronic liver diseaseSharing intranasal cocaine equipment[12,33]Poverty[34,35]
Percutaneous exposures to HCVHistory of sexually transmitted disease[12,33] with genital erosions[28]History of invasive procedures[36]
HaemophiliaTraumatic sex or vaginal sex during menstruation[14,33]History of surgery[36]
Children born to HCV + ve mothersHealth Care Workers performing procedures at risk of transmission to the patient[37]Beauty treatments[38]
HIV positivity
Stable sexual partners of HCV + patients